Literature DB >> 17518535

Post-Injury Administration of Mitochondrial Uncouplers Increases Tissue Sparing and Improves Behavioral Outcome following Traumatic Brain Injury in Rodents.

Jignesh D Pandya1, James R Pauly, Vidya N Nukala, Andrea H Sebastian, Kristen M Day, Amit S Korde, William F Maragos, Edward D Hall, Patrick G Sullivan.   

Abstract

Following experimental traumatic brain injury (TBI), a rapid and significant necrosis occurs at the site of injury which coincides with significant mitochondrial dysfunction. The present study is driven by the hypothesis that TBI-induced glutamate release increases mitochondrial Ca(2+)cycling/overload, ultimately leading to mitochondrial dysfunction. Based on this premise, mitochondrial uncoupling during the acute phases of TBI-induced excitotoxicity should reduce mitochondrial Ca(2+) uptake (cycling) and reactive oxygen species (ROS) production since both are mitochondrial membrane potential dependent. In the present study, we utilized a cortical impact model of TBI to assess the potential use of mitochondrial uncouplers (2,4-DNP, FCCP) as a neuroprotective therapy. Young adult male rats were intraperitoneally administered vehicle (DMSO), 2,4-DNP (5 mg/kg), or FCCP (2.5 mg/kg) at 5 min post-injury. All animals treated with the uncouplers demonstrated a significant reduction in the amount of cortical damage and behavioral improvement following TBI. In addition, mitochondria isolated from the injured cortex at 3 or 6 h post-injury demonstrated that treatment with the uncouplers significantly improved several parameters of mitochondrial bioenergetics. These results demonstrate that post-injury treatment with mitochondrial uncouplers significantly (p < 0.01) increases cortical tissue sparing ( approximately 12%) and significantly (p< 0.01) improves behavioral outcome following TBI. The mechanism of neuroprotection most likely involves the maintenance of mitochondrial homeostasis by reducing mitochondrial Ca(2+) loading and subsequent mitochondrial dysfunction. These results further implicate mitochondrial dysfunction as an early event in the pathophysiology of TBI and that targeting acute mitochondrial events can result in long-term neuroprotection and improve behavioral outcome following brain injury.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17518535     DOI: 10.1089/neu.2006.3673

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  61 in total

1.  Therapeutic window analysis of the neuroprotective effects of cyclosporine A after traumatic brain injury.

Authors:  Patrick G Sullivan; Andrea H Sebastian; Edward D Hall
Journal:  J Neurotrauma       Date:  2011-02-02       Impact factor: 5.269

Review 2.  Purines and neuronal excitability: links to the ketogenic diet.

Authors:  S A Masino; M Kawamura; D N Ruskin; J D Geiger; D Boison
Journal:  Epilepsy Res       Date:  2011-08-30       Impact factor: 3.045

3.  Late-onset intermittent fasting dietary restriction as a potential intervention to retard age-associated brain function impairments in male rats.

Authors:  Rumani Singh; Dinesh Lakhanpal; Sushil Kumar; Sandeep Sharma; Hardeep Kataria; Manpreet Kaur; Gurcharan Kaur
Journal:  Age (Dordr)       Date:  2011-08-23

4.  Nrf2-ARE activator carnosic acid decreases mitochondrial dysfunction, oxidative damage and neuronal cytoskeletal degradation following traumatic brain injury in mice.

Authors:  Darren M Miller; Indrapal N Singh; Juan A Wang; Edward D Hall
Journal:  Exp Neurol       Date:  2014-11-26       Impact factor: 5.330

5.  WldS prevents axon degeneration through increased mitochondrial flux and enhanced mitochondrial Ca2+ buffering.

Authors:  Michelle A Avery; Timothy M Rooney; Jignesh D Pandya; Thomas M Wishart; Thomas H Gillingwater; James W Geddes; Patrick G Sullivan; Marc R Freeman
Journal:  Curr Biol       Date:  2012-03-15       Impact factor: 10.834

6.  Therapeutic targeting of astrocytes after traumatic brain injury.

Authors:  Jessica Shields; Donald E Kimbler; Walid Radwan; Nathan Yanasak; Sangeetha Sukumari-Ramesh; Krishnan M Dhandapani
Journal:  Transl Stroke Res       Date:  2011-11-09       Impact factor: 6.829

Review 7.  Mitochondrial biogenesis as a therapeutic target for traumatic and neurodegenerative CNS diseases.

Authors:  Epiphani C Simmons; Natalie E Scholpa; Rick G Schnellmann
Journal:  Exp Neurol       Date:  2020-04-11       Impact factor: 5.330

Review 8.  Perspective: Does brown fat protect against diseases of aging?

Authors:  Mark P Mattson
Journal:  Ageing Res Rev       Date:  2009-12-05       Impact factor: 10.895

9.  Adenosine, ketogenic diet and epilepsy: the emerging therapeutic relationship between metabolism and brain activity.

Authors:  S A Masino; M Kawamura; C D Wasser; C A Wasser; L T Pomeroy; D N Ruskin
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

Review 10.  Mitochondria and neuroplasticity.

Authors:  Aiwu Cheng; Yan Hou; Mark P Mattson
Journal:  ASN Neuro       Date:  2010-10-04       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.